FutraMed Inc

FutraMed Inc. is a small company based in Sandy, Utah, founded in 2011. With a team of four employees, FutraMed focuses on developing innovative medical technologies. Their primary goal is to address the growing crisis of opioid dependence by providing alternative pain management solutions. The company's flagship product is the Limoge TCES, a patented, portable cranial stimulator. This hand-held device utilizes transcutaneous electrical cranial stimulation, a technology based on the work of Dr. Aimé Limoge of Paris, France. The Limoge TCES is designed to stabilize, reduce, or even replace opioid dosages for both acute and chronic pain management. FutraMed envisions the Limoge TCES as a tool to help individuals manage pain effectively while reducing their reliance on potentially addictive painkillers. FutraMed has already developed a fully functional and manufacturer-ready version of the Limoge TCES that meets international safety standards. The company is currently working with regulatory agencies to secure approval for public use. FutraMed highlights the simplicity, affordability, and portability of the Limoge TCES as key differentiators. For further information or inquiries, you can visit FutraMed's website at futramed.com.